Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 32.52M 37.79M 30.62M 27.9M 52.2M 3.6B 52.41M 363M 140M 1.83B 142M 139M 5.8B | P/E 2026 * |
-7.38x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 32.52M 37.79M 30.62M 27.9M 52.2M 3.6B 52.41M 363M 140M 1.83B 142M 139M 5.8B | EV / Sales 2026 * |
10.8x | EV / Sales 2027 * | 3.25x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 2024-02-27 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 2014-12-31 |
Emmet Purtill
PRN | Corporate Officer/Principal | - | 2005-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 2024-04-07 |
Damian Marron
CHM | Chairman | 64 | 2024-07-15 |
Marc Bozec
BRD | Director/Board Member | - | 2024-07-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 38.54M | |
| -0.63% | -2.71% | +74.36% | +35.29% | 366B | |
| -1.41% | -5.21% | +21.30% | -19.40% | 68.06B | |
| -0.85% | -2.07% | +41.17% | +178.86% | 12.29B | |
| -1.51% | -9.90% | -13.56% | -16.32% | 8.02B | |
| +0.72% | -2.90% | -23.40% | +2.32% | 4.86B | |
| +1.14% | -1.60% | -33.28% | +15.07% | 4.4B | |
| -1.63% | -1.38% | -35.25% | -7.78% | 3.01B | |
| -0.85% | -4.45% | -8.60% | +37.53% | 2.47B | |
| -1.31% | -2.44% | -25.62% | -19.48% | 1.99B | |
| Average | -1.43% | -3.71% | -0.32% | +22.90% | 52.37B | |
| Weighted average by Cap. | -0.74% | -1.77% | +60.77% | +29.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.49M 2.82M 2.57M 4.82M 332M 4.83M 33.48M 12.94M 169M 13.09M 12.81M 535M | 10M 11.62M 9.42M 8.58M 16.05M 1.11B 16.12M 112M 43.13M 563M 43.64M 42.69M 1.78B |
| Net income | -5M -5.81M -4.71M -4.29M -8.03M -553M -8.06M -55.8M -21.57M -282M -21.82M -21.34M -892M | 2M 2.32M 1.88M 1.72M 3.21M 221M 3.22M 22.32M 8.63M 113M 8.73M 8.54M 357M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
